[PDF][PDF] cDNA cloning and primary structure analysis of C1qRp, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro

RR Nepomuceno, AH Henschen-Edman, WH Burgess… - Immunity, 1997 - cell.com
RR Nepomuceno, AH Henschen-Edman, WH Burgess, AJ Tenner
Immunity, 1997cell.com
The complement protein C1q, mannose-binding lectin (MBL), and pulmonary surfactant
protein A (SPA) are structurally similar molecules that enhance phagocytic function in vitro.
Monoclonal antibodies R3 and R139, which inhibit the enhancement triggered by these
three ligands, were used to purify a 126,000 M r cell surface protein designated C1qR P.
Amino acid sequence was obtained and the corresponding cDNA was cloned. C1qR P is a
novel type I membrane protein with the following putative structural elements: a C-type …
Abstract
The complement protein C1q, mannose-binding lectin (MBL), and pulmonary surfactant protein A (SPA) are structurally similar molecules that enhance phagocytic function in vitro. Monoclonal antibodies R3 and R139, which inhibit the enhancement triggered by these three ligands, were used to purify a 126,000 Mr cell surface protein designated C1qRP. Amino acid sequence was obtained and the corresponding cDNA was cloned. C1qRP is a novel type I membrane protein with the following putative structural elements: a C-type carbohydrate recognition domain, five EGF-like domains, a transmembrane domain, and a short cytoplasmic tail. All peptides identified by amino acid sequencing are encoded by the cDNA. Additionally, an anti-peptide antiserum was generated, which is reactive with C1qRP. The data indicate that the cloned cDNA encodes the receptor that plays a role in C1q/MBL/SPA-mediated removal or destruction of pathogens and immune complexes by phagocytosis.
cell.com